¼¼°èÀÇ ³»½Ã°æ ¸ê±Õ ½ÃÀå
Endoscope Sterilization
»óǰÄÚµå : 1780749
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 369 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,204,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,612,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ³»½Ã°æ ¸ê±Õ ½ÃÀåÀº 2030³â±îÁö 38¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ³»½Ã°æ ¸ê±Õ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 8.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 38¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¸ê±Õ±â´Â CAGR 8.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 21¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾×ü È­ÇÐ ¸ê±Õ ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 9.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 3,440¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³»½Ã°æ ¸ê±Õ ½ÃÀåÀº 2024³â¿¡ 6¾ï 3,440¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8¾ï 2,350¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 13.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.3%¿Í 8.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³»½Ã°æ ¸ê±Õ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³»½Ã°æ ¸ê±ÕÀÌ È¯ÀÚ ¾ÈÀü¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

³»½Ã°æ ¸ê±ÕÀº ÀÇ·á ½Ã¼ú¿¡ »ç¿ëµÇ´Â ¿¬¼º ³»½Ã°æ°ú °æ¼º ³»½Ã°æ¿¡ À¯ÇØÇÑ ¹Ì»ý¹°ÀÌ Á¸ÀçÇÏÁö ¾Êµµ·Ï ÇÏ´Â °¨¿° °ü¸®ÀÇ Áß¿äÇÑ °úÁ¤ÀÔ´Ï´Ù. ³»½Ã°æÀº ¼ÒÈ­±â³»°ú, È£Èí±â³»°ú, ºñ´¢±â°ú, ºÎÀΰú, ÃÖ¼Òħ½À¼ö¼ú µî¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ¸ê±ÕÀº º´¿ø À§»ý ¹× ȯÀÚ ¾ÈÀü ÇÁ·ÎÅäÄÝ¿¡¼­ ¿ì¼±¼øÀ§°¡ ³ôÀº ºÐ¾ßÀÔ´Ï´Ù. ±æ°í ±ä ³»°­°ú ¼¶¼¼ÇÑ ±¤ÇÐ ºÎǰÀ» °¡Áø ³»½Ã°æ ±â±âÀÇ º¹À⼺À» °í·ÁÇÒ ¶§, 2Â÷ ¿À¿°°ú º´¿ø³» °¨¿°(HAI)À» ¿¹¹æÇϱâ À§Çؼ­´Â È¿°úÀûÀÎ ¸ê±ÕÀÌ ÇʼöÀûÀÔ´Ï´Ù.

³»½Ã°æ °ü·Ã °¨¿° ¹ß»ý·ü Áõ°¡, ÀÇ·á±â±â Àçó¸® °ü·Ã ±ÔÁ¦ °­È­, ÀÏȸ¿ë ³»½Ã°æ ÀåºñÀÇ »ç¿ë Áõ°¡·Î ÀÎÇØ ÷´Ü ¸ê±Õ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼öÀÛ¾÷ Àçó¸® ¹× °í¼öÁØ ¼Òµ¶(HLD)°ú °°Àº ÀüÅëÀûÀÎ ¼¼Ã´ ¹× ¼Òµ¶ ¹æ¹ýÀº º¸´Ù ½Å·ÚÇÒ ¼ö ÀÖ´Â Àú¿Â »ì±Õ ±â¼ú·Î º¸¿Ï ¶Ç´Â ´ëüµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ ³»½Ã°æ Àçó¸®(AER) ½Ã½ºÅÛ, ±âÈ­ °ú»êÈ­¼ö¼Ò(VHP) ¸ê±Õ, °úÃÊ»ê ±â¹Ý ¸ê±Õ ±â¼ú·ÎÀÇ ÀüȯÀº È¿À²¼ºÀ» °³¼±ÇÏ°í ¼öµ¿ ¸ê±ÕÀÇ ÀÎÀû ¿À·ù¿Í °ü·ÃµÈ À§ÇèÀ» ÁÙ¿´½À´Ï´Ù.

³»½Ã°æ ¸ê±ÕÀÇ ÁÖ¿ä ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

³»½Ã°æ ¸ê±ÕÀÇ ±â¼ú ¹ßÀüÀº ¹«±Õ¼º º¸Àå °­È­, »çÀÌŬ ½Ã°£ ´ÜÃà, Àç·á ÀûÇÕ¼º Çâ»ó¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. Àú¿Â °ú»êÈ­¼ö¼Ò ÇöóÁ ¸ê±Õ ½Ã½ºÅÛÀÇ °³¹ß·Î ±¤ÇÐ ¹× ÀüÀÚ ºÎǰÀÇ ¼Õ»ó ¾øÀÌ ¿­¿¡ Ãë¾àÇÑ ³»½Ã°æÀ» È¿°úÀûÀ¸·Î Àçó¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ UV-C ±¤»ì±Õ, ¿ÀÁ¸ »ì±Õ, Àü±â È­ÇÐÀû »êÈ­¿¡ ±â¹ÝÇÑ »ì±ÕÀº ±âÁ¸ÀÇ È­ÇÐÀû ¼Òµ¶Á¦¸¦ ´ëüÇÒ ¼ö ÀÖ´Â À¯¸Á ¹æ¹ýÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.

AI¸¦ Ȱ¿ëÇÑ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú RFID ±â¹Ý ÃßÀû ¼Ö·ç¼ÇÀÌ ÀÚµ¿ Àçó¸® Àåºñ¿¡ ÅëÇÕµÇ¾î ¸ê±Õ ÇÁ·ÎÅäÄÝ Áؼö¿Í ¹®¼­È­ÀÇ Á¤È®¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ½º¸¶Æ® ½Ã½ºÅÛÀº º´¿øÀÌ ¸ê±Õ Áֱ⸦ ÃßÀûÇϰí Àç¿À¿°À» ¹æÁöÇϸç FDA, CDC ¹× Joint CommissionÀÇ Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ¶ÇÇÑ Æ¯È÷ ±â°üÁö°æ °Ë»ç, ºñ´¢±â°ú, À̺ñÀÎÈİú ½Ã¼ú¿¡¼­ ÀÏȸ¿ë ³»½Ã°æÀÇ Á߿伺ÀÌ °­Á¶µÇ¸é¼­ ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ¸é¼­ ±âÁ¸ÀÇ ¸ê±Õ ¿öÅ©Ç÷ο쿡 ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙ¿© ½ÃÀåÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

³»½Ã°æ ¸ê±Õ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

³»½Ã°æ ¸ê±Õ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ³»½Ã°æ ¼ö¼ú Áõ°¡, HAI¿¡ ´ëÇÑ ¿ì·Á Áõ°¡, ÀÇ·á±â±â Àç󸮿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°ÇÀÇ °­È­ÀÔ´Ï´Ù. ÀÚµ¿È­ ¹× Ç¥ÁØÈ­µÈ ¸ê±Õ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àú¿Â ¸ê±Õ ±â¼úÀÇ ¹ßÀü, ÀÏȸ¿ë ³»½Ã°æÀ¸·ÎÀÇ Àüȯ µîÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¨¿° ¿¹¹æ¿¡ ´ëÇÑ ÇコÄɾî ÅõÀÚ Áõ°¡¿Í Àü ¼¼°è ³»½Ã°æ ¼¾ÅÍÀÇ È®ÀåÀº °íÈ¿À² ¸ê±Õ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á½Ã¼³ÀÌ È¯ÀÚÀÇ ¾ÈÀü°ú ±ÔÁ¤ Áؼö¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, Â÷¼¼´ë ¸ê±Õ ±â¼ú, AI¸¦ Ȱ¿ëÇÑ ÃßÀû, ģȯ°æ ¼Òµ¶ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³»½Ã°æ Àçó¸® ¹× ÀÏȸ¿ë ±â±â °³¹ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î ³»½Ã°æ ¸ê±Õ ½ÃÀåÀº ÇâÈÄ ¼ö³â°£ Å« ¹ßÀüÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(¸ê±Õ±â, ¾×ü È­ÇÐ ¸ê±Õ ½Ã½ºÅÛ, ÀÚµ¿ ³»½Ã°æ Àç󸮱â(AER)), À¯Çü(¿¬¼º ³»½Ã°æ, °æ¼º ³»½Ã°æ), µð¹ÙÀ̽º À¯Çü(´ëÀå³»½Ã°æ, ±â°üÁö ³»½Ã°æ, ½ÊÀÌÁöÀå ³»½Ã°æ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

°ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇÕ´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Endoscope Sterilization Market to Reach US$3.8 Billion by 2030

The global market for Endoscope Sterilization estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Sterilizers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Liquid Chemical Sterilization Systems segment is estimated at 9.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$634.4 Million While China is Forecast to Grow at 13.2% CAGR

The Endoscope Sterilization market in the U.S. is estimated at US$634.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$823.5 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Endoscope Sterilization Market - Key Trends & Drivers Summarized

Why Is Endoscope Sterilization Essential for Patient Safety?

Endoscope sterilization is a critical process in infection control, ensuring that flexible and rigid endoscopes used in medical procedures remain free from harmful microorganisms. Endoscopes are widely utilized in gastroenterology, pulmonology, urology, gynecology, and minimally invasive surgeries, making sterilization a high-priority area in hospital hygiene and patient safety protocols. Given the complexity of endoscopic instruments, which have long, narrow lumens and delicate optical components, effective sterilization is essential to prevent cross-contamination and hospital-acquired infections (HAIs).

The rising incidence of endoscope-related infections, regulatory scrutiny on medical device reprocessing, and increasing adoption of single-use endoscopic devices have intensified the demand for advanced sterilization techniques. Traditional cleaning and disinfection methods, such as manual reprocessing and high-level disinfection (HLD), are being supplemented or replaced by more reliable low-temperature sterilization technologies. The shift toward automated endoscope reprocessing (AER) systems, vaporized hydrogen peroxide (VHP) sterilization, and peracetic acid-based sterilization techniques is improving efficiency and reducing risks associated with human error in manual sterilization.

What Are the Key Innovations in Endoscope Sterilization?

Technological advancements in endoscope sterilization have focused on enhancing sterility assurance, reducing cycle time, and improving material compatibility. The development of low-temperature hydrogen peroxide plasma sterilization systems has enabled effective reprocessing of heat-sensitive endoscopes without damaging optical or electronic components. Additionally, UV-C light sterilization, ozone sterilization, and electrochemical oxidation-based sterilization are emerging as promising alternatives to traditional chemical disinfectants.

The integration of AI-powered monitoring systems and RFID-based tracking solutions in automated reprocessing units has enhanced compliance with sterilization protocols and documentation accuracy. These smart systems help hospitals track sterilization cycles, prevent recontamination, and ensure compliance with FDA, CDC, and Joint Commission standards. Additionally, the growing emphasis on single-use endoscopes, particularly in bronchoscopy, urology, and ENT procedures, is reshaping the market, reducing dependence on traditional sterilization workflows while improving patient safety.

What Is Driving the Growth of the Endoscope Sterilization Market?

The growth in the endoscope sterilization market is driven by increasing endoscopic procedures, rising concerns over HAIs, and stricter regulatory requirements for medical device reprocessing. The growing demand for automated and standardized sterilization solutions, advancements in low-temperature sterilization technologies, and the shift toward disposable endoscopes have contributed to market expansion. Additionally, rising healthcare investments in infection prevention and the expansion of endoscopy centers globally are fueling demand for high-efficiency sterilization systems.

As healthcare facilities prioritize patient safety and compliance, the adoption of next-generation sterilization technologies, AI-powered tracking, and eco-friendly disinfection solutions is expected to drive sustained growth. With continued innovation in endoscopic reprocessing and single-use device development, the endoscope sterilization market is set for significant advancements in the coming years.

SCOPE OF STUDY:

The report analyzes the Endoscope Sterilization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sterilizers, Liquid Chemical Sterilization Systems, Automated Endoscope Reprocessors (AERs); Type (Flexible Endoscopes, Rigid Endoscopes); Device Type (Colonoscopes, Bronchoscopes, Duodenoscopes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â